Eesti - eesti - Ravimiamet

mylan pharmaceuticals limited - agomelatiin - õhukese polümeerikattega tablett - 25mg 98tk; 25mg 28tk; 25mg 56tk; 25mg 42tk; 25mg 100tk

Eesti - eesti - Ravimiamet

krka d.d. novo mesto - tadalafiil - õhukese polümeerikattega tablett - 2,5mg 8tk; 2,5mg 28tk; 2,5mg 14tk; 2,5mg 12tk; 2,5mg 4tk; 2,5mg 2tk; 2,5mg 84tk; 2,5mg 56tk

Eesti - eesti - Ravimiamet

zentiva k.s. - agomelatiin - õhukese polümeerikattega tablett - 25mg 84tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

koanaa healthcare gmbh - imatinib mesilate - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma; gastrointestinal stromal tumors - antineoplastilised ained - imatinib koanaa is indicated for the treatment ofadult and paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment. adult and paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. adult and paediatric patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph+ all as monotherapy. adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfrα rearrangement. the effect of imatinib on the outcome of bone marrow transplantation has not been determined. imatinib koanaa is indicated forthe treatment of adult patients with kit (cd 117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). the adjuvant treatment of adult patients who are at significant risk of relapse following resection of kit (cd117)-positive gist. patsientidel, kellel on madal või väga madal risk kordumise ei tohiks saada abiaine ravi. the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic gist and dfsp and on recurrence-free survival in adjuvant gist. the experience with imatinib in patients with mds/mpd associated with pdgfr gene re-arrangements is very limited (see section 5. välja arvatud äsja diagnoositud kroonilise faasi cml, ei ole kontrollitud uuringud, mis näitab kliiniline kasu või suurenenud ellujäämise eest need haigused.

Euroopa Liit - eesti - EMA (European Medicines Agency)

viiv healthcare bv - lamivudine, zidovudine - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.

Euroopa Liit - eesti - EMA (European Medicines Agency)

teva pharma b.v.  - lamivudine, zidovudine - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - lamivudiin / zidovudine teva on näidustatud inimese immuunpuudulikkuse viiruse (hiv) infektsiooni raviks retroviirusevastases kombinatsioonravis..

Eesti - eesti - Ravimiamet

orifarm healthcare a/s - kaltsium+kolekaltsiferool - närimistablett - 500mg+200rÜ 60tk; 500mg+200rÜ 120tk; 500mg+200rÜ 30tk; 500mg+200rÜ 90tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - karvedilool - tablett - 25mg 28tk; 25mg 250tk; 25mg 50tk; 25mg 10tk; 25mg 20tk; 25mg 56tk; 25mg 14tk; 25mg 60tk; 25mg 30tk; 25mg 98tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - karvedilool - tablett - 12,5mg 100tk; 12,5mg 20tk; 12,5mg 250tk; 12,5mg 98tk; 12,5mg 10tk; 12,5mg 56tk; 12,5mg 50tk; 12,5mg 28tk; 12,5mg 30tk

Eesti - eesti - Ravimiamet

krka, d.d., novo mesto - karvedilool - tablett - 6,25mg 60tk; 6,25mg 100tk; 6,25mg 20tk; 6,25mg 50tk; 6,25mg 10tk; 6,25mg 28tk; 6,25mg 14tk; 6,25mg 250tk